Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sambucol is a leading consumer healthcare brand specializing in black elderberry (Sambucus nigra) supplements designed to support the immune system. Developed by a world-renowned virologist in 1991, the brand's products are based on a proprietary extraction process that preserves the natural benefits of the berries' antioxidants, specifically anthocyanins. Sambucol offers a wide range of formulations, including syrups, gummies, tablets, and powders, marketed globally for the prevention and relief of cold and flu symptoms. The brand is currently owned and managed by PharmaCare Laboratories, a major international health and wellness company. Its efficacy has been explored in various clinical studies focusing on viral replication and immune response.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sambucol.